Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb74510f0987793b6784fc84fb9a9a96 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-58 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-58 |
filingDate |
2013-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c29ea156cfb9a0340212bb3fdcd97424 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61f4d6001bb9010d85f25aa2ecaa859e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5db4af3516726ce81eda146184d4648 |
publicationDate |
2015-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-102013004752-A2 |
titleOfInvention |
Process for medetomidine transformation and unwanted enantiomer recovery |
abstract |
Process for transformation of medetomidine and recovery of unwanted enantiomer. The present invention relates to a process for obtaining medetomidine enantiomers, a potent and selective β 2 receptor agonist. Such a process comprises a transformation stage and a racemization reaction, allowing recovery of unwanted enantiomer which can be recycled as a starting material. |
priorityDate |
2012-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |